Finance ❯ Investment ❯ Venture Capital ❯ Funding Rounds

Series C Funding

NewLimit Raises $435 Million to Advance First Human Trial for Liver Rejuvenation

The capital will fund preparations for regulatory filings to test a transcription-factor therapy delivered by lipid nanoparticles in humans targeted for 2027.

4 ARTICLES

last mo.

Slate Opens Preorders for Low-Cost EV Truck on June 24

11 ARTICLES

2mo ago

Slate Auto Raises $650 Million to Build Ultra-Low-Cost Modular EV Truck

9 ARTICLES

3mo ago

Rebellions Raises $400 Million in Pre-IPO Round Led by Mirae Asset and Korea Growth Fund

5 ARTICLES

7mo ago

Harbinger Raises $160 Million as FedEx Invests and Orders 53 Electric Truck Chassis